These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2659724)

  • 1. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
    Cross AS; Sadoff JC; Kelly N; Bernton E; Gemski P
    J Exp Med; 1989 Jun; 169(6):2021-7. PubMed ID: 2659724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli.
    Cross A; Asher L; Seguin M; Yuan L; Kelly N; Hammack C; Sadoff J; Gemski P
    J Clin Invest; 1995 Aug; 96(2):676-86. PubMed ID: 7635960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.
    Wielockx B; Hochepied T; Staelens J; Van Molle W; Brouckaert P; Libert C
    Cytokine; 2001 Jul; 15(2):59-65. PubMed ID: 11500080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection.
    Wang M; Jeng KC; Ping LI
    Immunology; 1999 Sep; 98(1):90-7. PubMed ID: 10469238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitis.
    Lange JR; Alexander HR; Merino MJ; Doherty GM; Norton JA
    J Surg Res; 1992 Jun; 52(6):555-9. PubMed ID: 1528030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.
    Waage A; Espevik T
    J Exp Med; 1988 Jun; 167(6):1987-92. PubMed ID: 3290384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Beutler B; Milsark IW; Cerami AC
    Science; 1985 Aug; 229(4716):869-71. PubMed ID: 3895437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production.
    Zhang H; Peterson JW; Niesel DW; Klimpel GR
    J Immunol; 1997 Nov; 159(10):4868-78. PubMed ID: 9366412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
    Fong Y; Tracey KJ; Moldawer LL; Hesse DG; Manogue KB; Kenney JS; Lee AT; Kuo GC; Allison AC; Lowry SF
    J Exp Med; 1989 Nov; 170(5):1627-33. PubMed ID: 2809510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal enterotoxin B induces hepatic injury and lethal shock in endotoxin-resistant C3H/HeJ mice despite a deficient macrophage response.
    Yasuda S; Nagaki M; Moriwaki H
    J Endotoxin Res; 2002; 8(4):253-61. PubMed ID: 12230915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor.
    Alexander HR; Wong GG; Doherty GM; Venzon DJ; Fraker DL; Norton JA
    J Exp Med; 1992 Apr; 175(4):1139-42. PubMed ID: 1552284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
    J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention.
    Butler LD; Layman NK; Cain RL; Riedl PE; Mohler KM; Bobbitt JL; Belagajie R; Sharp J; Bendele AM
    Clin Immunol Immunopathol; 1989 Dec; 53(3):400-21. PubMed ID: 2680192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor.
    DeMaria EJ; Pellicane JV; Lee RB
    J Trauma; 1993 Nov; 35(5):720-4; discussion 724-5. PubMed ID: 8230336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TNF and IL-1 in infections with Toxoplasma gondii.
    Chang HR; Grau GE; Pechère JC
    Immunology; 1990 Jan; 69(1):33-7. PubMed ID: 2107144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice.
    Memon RA; Grunfeld C; Moser AH; Feingold KR
    Endocrinology; 1993 May; 132(5):2246-53. PubMed ID: 8477669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary.
    Silverstein R; Turley BR; Christoffersen CA; Johnson DC; Morrison DC
    J Exp Med; 1991 Feb; 173(2):357-65. PubMed ID: 1988538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1.
    Sipe JD; Vogel SN; Douches S; Neta R
    Lymphokine Res; 1987; 6(2):93-101. PubMed ID: 3495710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.